patient_nbr
int64
135
190M
Patient context and readmission decision formatted for training
stringlengths
1.99k
2.15k
8,778,510
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 34. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 250.01. Additional secondary diagnosis (coded as first three digits of ICD9): 411. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
45,144
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [10-20). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 13. Payer code: ?. Medical speciality of the admitting physician: Pediatrics-Pulmonology. Number of lab tests performed during the encounter: 56. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 482. The secondary diagnosis (coded as first three digits of ICD9): 277. Additional secondary diagnosis (coded as first three digits of ICD9): 250.03. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: >7. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
352,377
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 55. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 18. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.6. The secondary diagnosis (coded as first three digits of ICD9): 707. Additional secondary diagnosis (coded as first three digits of ICD9): 357. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>
3,186,981
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 30. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 7. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 434. The secondary diagnosis (coded as first three digits of ICD9): 435. Additional secondary diagnosis (coded as first three digits of ICD9): 780. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
22,757,895
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 52. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 496. Additional secondary diagnosis (coded as first three digits of ICD9): 780. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
470,754
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: Surgery-General. Number of lab tests performed during the encounter: 63. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 18. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 575. The secondary diagnosis (coded as first three digits of ICD9): 998. Additional secondary diagnosis (coded as first three digits of ICD9): 780. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
1,101,294
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 70. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 780. The secondary diagnosis (coded as first three digits of ICD9): 426. Additional secondary diagnosis (coded as first three digits of ICD9): 496. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
3,467,412
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 35. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 6. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 250.6. Additional secondary diagnosis (coded as first three digits of ICD9): 250.41. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
9,025,047
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 47. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 10. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 401. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Up. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
9,029,196
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [10-20). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Pediatrics-Endocrinology. Number of lab tests performed during the encounter: 50. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 5. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.03. The secondary diagnosis (coded as first three digits of ICD9): ?. Additional secondary diagnosis (coded as first three digits of ICD9): ?. Number of diagnosis: 1. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
70,269,183
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Hispanic. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 48. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 18. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 434. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 250.6. Number of diagnosis: 5. Max_glu_serum test result: >300. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
5,047,470
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: Surgery-Cardiovascular/Thoracic. Number of lab tests performed during the encounter: 47. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 202. The secondary diagnosis (coded as first three digits of ICD9): 512. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
686,988
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 9. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 46. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 23. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 786. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 531. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
28,766,817
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 69. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 250.03. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
4,571,388
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [30-40). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 36. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 10. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 493. The secondary diagnosis (coded as first three digits of ICD9): 250.02. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 3. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
2,892,654
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [10-20). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 48. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 6. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 2. The primary diagnosis (coded as first three digits of ICD9): 250.13. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): 250.23. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
1,422,432
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Endocrinology. Number of lab tests performed during the encounter: 46. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 15. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.83. The secondary diagnosis (coded as first three digits of ICD9): 996. Additional secondary diagnosis (coded as first three digits of ICD9): 428. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
8,039,988
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Transfer from a hospital. Number of days between admission and discharge: 9. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 70. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 33. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 285. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
111,555
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 61. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 280. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 496. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
5,193,639
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 10. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 71. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 41. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 997. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: Up. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
1,502,829
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 66. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 414. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 3. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: Steady. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
522,342
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 34. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 10. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 250.01. Additional secondary diagnosis (coded as first three digits of ICD9): 278. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
1,957,212
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Not Mapped. Number of days between admission and discharge: 8. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 24. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 31. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 189. The secondary diagnosis (coded as first three digits of ICD9): 401. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
6,288,831
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 48. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 2. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.02. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): ?. Number of diagnosis: 2. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
1,606,311
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: Endocrinology. Number of lab tests performed during the encounter: 44. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 562. The secondary diagnosis (coded as first three digits of ICD9): 280. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
1,791,090
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [10-20). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Pediatrics. Number of lab tests performed during the encounter: 23. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 5. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 682. The secondary diagnosis (coded as first three digits of ICD9): 682. Additional secondary diagnosis (coded as first three digits of ICD9): 250.03. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
7,443,135
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [0-10). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Pediatrics. Number of lab tests performed during the encounter: 11. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 493. The secondary diagnosis (coded as first three digits of ICD9): 250.03. Additional secondary diagnosis (coded as first three digits of ICD9): 714. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
89,177,013
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [80-90). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 50. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 427. Additional secondary diagnosis (coded as first three digits of ICD9): 459. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
90,460,242
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to another short term hospital. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 63. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 18. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 2. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 599. Additional secondary diagnosis (coded as first three digits of ICD9): 403. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>
100,510,452
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 64. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 33. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 553. The secondary diagnosis (coded as first three digits of ICD9): 496. Additional secondary diagnosis (coded as first three digits of ICD9): 427. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
4,765,626
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 42. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 560. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
435,366
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: Urology. Number of lab tests performed during the encounter: 12. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 997. The secondary diagnosis (coded as first three digits of ICD9): 780. Additional secondary diagnosis (coded as first three digits of ICD9): E878. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:<30 days. </s>
73,154,043
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [40-50). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 37. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 10. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 599. The secondary diagnosis (coded as first three digits of ICD9): 290. Additional secondary diagnosis (coded as first three digits of ICD9): 437. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
4,729,023
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Orthopedics-Reconstructive. Number of lab tests performed during the encounter: 54. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 20. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 715. The secondary diagnosis (coded as first three digits of ICD9): 401. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 3. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: Steady. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
3,778,047
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Surgery-General. Number of lab tests performed during the encounter: 39. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 789. The secondary diagnosis (coded as first three digits of ICD9): 401. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
2,464,146
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: Gastroenterology. Number of lab tests performed during the encounter: 56. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 577. The secondary diagnosis (coded as first three digits of ICD9): 250.6. Additional secondary diagnosis (coded as first three digits of ICD9): 733. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
333,252
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [80-90). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: Surgery-Colon&Rectal. Number of lab tests performed during the encounter: 49. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 154. The secondary diagnosis (coded as first three digits of ICD9): 196. Additional secondary diagnosis (coded as first three digits of ICD9): 507. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: Norm. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
2,425,617
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 56. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 15. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 560. The secondary diagnosis (coded as first three digits of ICD9): 535. Additional secondary diagnosis (coded as first three digits of ICD9): 714. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
86,797,872
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Neonate discharged to another hospital for neonatal aftercare. admission_source: Emergency Room. Number of days between admission and discharge: 9. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 72. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 434. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 250.01. Number of diagnosis: 5. Max_glu_serum test result: >200. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
4,225,995
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Surgery-General. Number of lab tests performed during the encounter: 32. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 21. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 682. The secondary diagnosis (coded as first three digits of ICD9): 707. Additional secondary diagnosis (coded as first three digits of ICD9): 250.7. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: Steady. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
8,922,573
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 70. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 250. Additional secondary diagnosis (coded as first three digits of ICD9): 272. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: Norm. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
4,065,975
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [30-40). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ObstetricsandGynecology. Number of lab tests performed during the encounter: 33. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 1. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 648. The secondary diagnosis (coded as first three digits of ICD9): 250.93. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
83,120,292
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [40-50). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 37. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 20. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 722. The secondary diagnosis (coded as first three digits of ICD9): 250. Additional secondary diagnosis (coded as first three digits of ICD9): ?. Number of diagnosis: 2. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
688,842
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [20-30). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ObstetricsandGynecology. Number of lab tests performed during the encounter: 49. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 1. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 648. The secondary diagnosis (coded as first three digits of ICD9): 250.02. Additional secondary diagnosis (coded as first three digits of ICD9): 525. Number of diagnosis: 3. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
8,035,524
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [30-40). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: ObstetricsandGynecology. Number of lab tests performed during the encounter: 46. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 648. The secondary diagnosis (coded as first three digits of ICD9): 642. Additional secondary diagnosis (coded as first three digits of ICD9): 250.53. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
719,487
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 10. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 51. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 599. The secondary diagnosis (coded as first three digits of ICD9): 403. Additional secondary diagnosis (coded as first three digits of ICD9): 996. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
647,181
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 36. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 435. The secondary diagnosis (coded as first three digits of ICD9): 427. Additional secondary diagnosis (coded as first three digits of ICD9): 437. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
687,978
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 53. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 20. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.22. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 403. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: Steady. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
6,884,595
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [10-20). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Pediatrics-Endocrinology. Number of lab tests performed during the encounter: 52. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 5. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.13. The secondary diagnosis (coded as first three digits of ICD9): 536. Additional secondary diagnosis (coded as first three digits of ICD9): ?. Number of diagnosis: 2. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
1,426,698
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged/transferred to home with home health service. admission_source: Transfer from a hospital. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 49. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 21. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 398. Additional secondary diagnosis (coded as first three digits of ICD9): 397. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
99,109,602
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to home with home health service. admission_source: Emergency Room. Number of days between admission and discharge: 10. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 59. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 332. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): 428. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
27,936
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [80-90). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 9. Payer code: ?. Medical speciality of the admitting physician: Surgery-General. Number of lab tests performed during the encounter: 34. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 441. The secondary diagnosis (coded as first three digits of ICD9): 444. Additional secondary diagnosis (coded as first three digits of ICD9): 805. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
4,696,065
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: Orthopedics-Reconstructive. Number of lab tests performed during the encounter: 50. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 18. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 715. The secondary diagnosis (coded as first three digits of ICD9): 496. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Up. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
4,582,233
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 57. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 15. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 599. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): 250.51. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
8,308,170
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Transfer from a hospital. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 44. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 250.02. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: Steady. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
104,789,817
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged/transferred to home with home health service. admission_source: Physician Referral. Number of days between admission and discharge: 13. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 37. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 3. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 276. The secondary diagnosis (coded as first three digits of ICD9): 250.02. Additional secondary diagnosis (coded as first three digits of ICD9): 437. Number of diagnosis: 5. Max_glu_serum test result: >300. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
83,898,765
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged/transferred to another type of inpatient care institution. admission_source: Transfer from a hospital. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 35. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 250.01. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>
482,958
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 38. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 272. Additional secondary diagnosis (coded as first three digits of ICD9): 305. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
6,167,682
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Transfer from a hospital. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 17. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 272. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
99,941,634
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 78. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 36. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
55,861,758
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 75. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 20. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 202. The secondary diagnosis (coded as first three digits of ICD9): 203. Additional secondary diagnosis (coded as first three digits of ICD9): 453. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>
9,124,884
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Other. Gender: Male. Age: [0-10). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Pediatrics-Endocrinology. Number of lab tests performed during the encounter: 50. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 5. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.03. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): ?. Number of diagnosis: 2. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
8,946,090
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [80-90). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: Neurology. Number of lab tests performed during the encounter: 41. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 5. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 434. The secondary diagnosis (coded as first three digits of ICD9): 342. Additional secondary diagnosis (coded as first three digits of ICD9): 784. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
5,973,228
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [80-90). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 44. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 4. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.81. The secondary diagnosis (coded as first three digits of ICD9): 401. Additional secondary diagnosis (coded as first three digits of ICD9): 244. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
1,147,545
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 14. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 71. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 32. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 486. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 276. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
21,943,170
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 12. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 69. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 349. The secondary diagnosis (coded as first three digits of ICD9): 250.02. Additional secondary diagnosis (coded as first three digits of ICD9): 331. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
1,355,697
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: Surgery-Neuro. Number of lab tests performed during the encounter: 48. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): ?. The secondary diagnosis (coded as first three digits of ICD9): 780. Additional secondary diagnosis (coded as first three digits of ICD9): 997. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
5,997,636
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Orthopedics-Reconstructive. Number of lab tests performed during the encounter: 52. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 715. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): 736. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
3,489,048
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 9. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 56. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 24. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 557. The secondary diagnosis (coded as first three digits of ICD9): 70. Additional secondary diagnosis (coded as first three digits of ICD9): 496. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
886,266
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: ?. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 46. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
78,398,298
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Hispanic. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged/transferred to SNF. admission_source: Physician Referral. Number of days between admission and discharge: 9. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 47. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 31. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 996. The secondary diagnosis (coded as first three digits of ICD9): 711. Additional secondary diagnosis (coded as first three digits of ICD9): 402. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
6,035,463
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [80-90). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 35. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 4. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 962. The secondary diagnosis (coded as first three digits of ICD9): 303. Additional secondary diagnosis (coded as first three digits of ICD9): 250.8. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
1,734,102
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: Surgery-Cardiovascular/Thoracic. Number of lab tests performed during the encounter: 27. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 5. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 996. The secondary diagnosis (coded as first three digits of ICD9): E878. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 3. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:<30 days. </s>
3,344,895
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: Urology. Number of lab tests performed during the encounter: 30. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 592. The secondary diagnosis (coded as first three digits of ICD9): 250.01. Additional secondary diagnosis (coded as first three digits of ICD9): 591. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
112,077,396
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to another short term hospital. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: Pulmonology. Number of lab tests performed during the encounter: 60. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 446. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
2,029,716
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: Nephrology. Number of lab tests performed during the encounter: 44. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 15. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 707. The secondary diagnosis (coded as first three digits of ICD9): 41. Additional secondary diagnosis (coded as first three digits of ICD9): 403. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: Norm. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
645,309
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Hispanic. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: Pulmonology. Number of lab tests performed during the encounter: 75. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 507. The secondary diagnosis (coded as first three digits of ICD9): 255. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
289,908
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 52. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.8. The secondary diagnosis (coded as first three digits of ICD9): 403. Additional secondary diagnosis (coded as first three digits of ICD9): 425. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
1,159,938
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 61. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 10. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 427. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
76,024,827
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 38. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 6. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 386. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 427. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
3,252,960
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 73. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 575. The secondary diagnosis (coded as first three digits of ICD9): 427. Additional secondary diagnosis (coded as first three digits of ICD9): 576. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
4,161,582
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 10. Payer code: ?. Medical speciality of the admitting physician: Surgery-General. Number of lab tests performed during the encounter: 32. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 6. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 276. The secondary diagnosis (coded as first three digits of ICD9): V44. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
1,524,294
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 37. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 5. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 682. The secondary diagnosis (coded as first three digits of ICD9): 242. Additional secondary diagnosis (coded as first three digits of ICD9): 715. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
300,825
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 60. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 682. The secondary diagnosis (coded as first three digits of ICD9): 38. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
105,143,886
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 39. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 20. Number of outpatient visits of the patient in the year preceding the encounter: 1. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 411. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
952,029
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [10-20). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: Anesthesiology-Pediatric. Number of lab tests performed during the encounter: 43. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.13. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): 465. Number of diagnosis: 3. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
1,719,279
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 47. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 24. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 682. Additional secondary diagnosis (coded as first three digits of ICD9): 584. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: Steady. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>
2,241,153
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 60. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.02. The secondary diagnosis (coded as first three digits of ICD9): 401. Additional secondary diagnosis (coded as first three digits of ICD9): ?. Number of diagnosis: 2. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Up. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
6,564,861
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 10. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 37. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 28. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 200. The secondary diagnosis (coded as first three digits of ICD9): 788. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
497,439
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 50. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 20. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 703. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: >7. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
331,920
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: Surgery-General. Number of lab tests performed during the encounter: 53. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 4. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 728. The secondary diagnosis (coded as first three digits of ICD9): 250.7. Additional secondary diagnosis (coded as first three digits of ICD9): 787. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
92,948,409
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: ?. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 52. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 348. The secondary diagnosis (coded as first three digits of ICD9): 413. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
4,118,256
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Pulmonology. Number of lab tests performed during the encounter: 57. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 599. The secondary diagnosis (coded as first three digits of ICD9): 250.02. Additional secondary diagnosis (coded as first three digits of ICD9): 41. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: Steady. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
29,952,900
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from another health care facility. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 61. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 425. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: Steady. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
293,967
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 42. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 414. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
8,891,883
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: Emergency/Trauma. Number of lab tests performed during the encounter: 42. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 10. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 434. The secondary diagnosis (coded as first three digits of ICD9): 427. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
5,521,167
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [30-40). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Gastroenterology. Number of lab tests performed during the encounter: 30. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 558. The secondary diagnosis (coded as first three digits of ICD9): 250. Additional secondary diagnosis (coded as first three digits of ICD9): 349. Number of diagnosis: 3. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>
2,579,661
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 36. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 5. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 424. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
3,538,080
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Nephrology. Number of lab tests performed during the encounter: 54. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 584. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): 403. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
9,037,764
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [90-100). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 45. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 7. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 459. The secondary diagnosis (coded as first three digits of ICD9): 250. Additional secondary diagnosis (coded as first three digits of ICD9): ?. Number of diagnosis: 2. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>